Home / Stocks / TSHA

TSHA insider trading

Taysha Gene Therapies, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$2.1M
Buys · last 90 days
0 · $0
Most recent buy
2025-06-03

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-10Nagendran Sukumar
President and Head of R&D
Sold200,000$6.24$1.2M
2025-12-01Nagendran Sukumar
President and Head of R&D
Sold260,047$4.51$1.2M
2025-06-03Manning Paul B
10% owner
Bought750,000$2.75$2.1M

Most active insider buyers

InsiderRoleBuysTotal bought
Manning Paul B10% owner1$2.1M

See TSHA on the chart

Every insider buy and sell for TSHA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.